Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Monger, Jo"'
Autor:
Orgaz, José L., Crosas-Molist, Eva, Sadok, Amine, Perdrix-Rosell, Anna, Maiques, Óscar, Rodriguez-Hernandez, Irene, Monger, Jo, Lee, Rebecca, Wallberg, Fredrik, Tape, Chris
Trabajo presentado en el 19th International Congress of the Society For Melanoma Research, celebrado en Edimburgo (Escocia) del 17 al 20 de octubre de 2022.
MAPK-targeted therapies (MAPKi) and immune checkpoint blockers (ICB) improve survival of
MAPK-targeted therapies (MAPKi) and immune checkpoint blockers (ICB) improve survival of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1106::eb9da03074fc29990f58ba1f927e46be
http://hdl.handle.net/10261/308871
http://hdl.handle.net/10261/308871
Autor:
Orgaz, Jose L., Crosas-Molist, Eva, Sadok, Amine, Perdrix-Rosell, Anna, Maiques, Óscar, Rodriguez-Hernandez, Irene, Monger, Jo, Lee, Rebecca, Wallberg, Fredrik, Tape, Chris, Karagiannis, Sophia N., Malanchi, Ilaria, Sanz-Moreno, Victoria
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
Trabajo presentado en la EACR-AstraZeneca Virtual Conference ‘Drug Tolerant Persister Cells’, celebrada del 07 al 08 de diciembre de 2021.
MAPK-targeted therapies (MAPKi) and immune checkpoint blockers (ICB) improve survival of subsets of me
MAPK-targeted therapies (MAPKi) and immune checkpoint blockers (ICB) improve survival of subsets of me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::4f82f8e7a82390154d2cbef04d1889a2
http://hdl.handle.net/10261/266071
http://hdl.handle.net/10261/266071
Autor:
Orgaz, Jose L., Crosas-Molist, Eva, Sadok, Amine, Perdrix-Rosell, Anna, Rodriguez-Hernandez, Irene, Monger, Jo, Lee, Rebecca, Wallberg, Fredrik, Tape, Chris, Karagiannis, Sophia N., Malanchi, Ilaria, Sanz-Moreno, Victoria
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
Trabajo presentado en el 3rd ASEICA Educational Symposium, celebrado en modalidad virtual del 23 al 25 de noviembre de 2021.
MAPK-targeted therapies (MAPKi) and immune checkpoint blockers (ICB) improve survival of subsets of melanoma patients. H
MAPK-targeted therapies (MAPKi) and immune checkpoint blockers (ICB) improve survival of subsets of melanoma patients. H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0f7ac6fb5f933900065c571635bc5379
http://hdl.handle.net/10261/265865
http://hdl.handle.net/10261/265865
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Monger, John D.
Thesis (M.F.A.)--Northern Michigan University, 2009.
Bibliography: leaves 195-198.
Bibliography: leaves 195-198.